Skip to Main Content

Author Details

Stephen E Kurtz
Knight Cancer Institute, Oregon Health and Science University
1979
43
19
PMIDPaper TitleJournal TitlePublished Year
37698624Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy.Blood Cancer Discov2023
33375770Genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways mediating sorafenib resistance in acute myeloid leukemia.Haematologica2022
35499387Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia.Mol Cancer Ther2022
35365596Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.Signal Transduct Target Ther2022
35868306Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.Cancer Cell2022
35185150Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.Signal Transduct Target Ther2022
35296646Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma.Cell Death Dis2022
35078224Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia.Blood Adv2022
34233959Pharmacologic Targeting of Mcl-1 Induces Mitochondrial Dysfunction and Apoptosis in B-Cell Lymphoma Cells in a <i>TP53-</i> and <i>BAX-</i>Dependent Manner.Clin Cancer Res2021
34302041Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia.NPJ Precis Oncol2021
32482750Keys to drug sensitivity from updated functional work flows.Haematologica2020
32094466Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia.Leukemia2020
30642575Predicting response to BET inhibitors using computational modeling: A BEAT AML project study.Leuk Res2019
31048320The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells.Cancer Discov2019
29534598Long-Term Outcomes From Repeated Smoking Cessation Assistance in Routine Primary Care.Am J Health Promot2018
30082821Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia.Leukemia2018
30333627Functional genomic landscape of acute myeloid leukaemia.Nature2018
29743719Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes.Leukemia2018
28784769Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies.Proc Natl Acad Sci U S A2017
28412732Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.Oncotarget2017
25921356Assessing Trends in Tobacco Cessation in Diverse Patient Populations.Nicotine Tob Res2016
26138036CER Hub: An informatics platform for conducting comparative effectiveness research using multi-institutional, heterogeneous, electronic clinical data.Int J Med Inform2015
24773327Documentation of the 5 as for smoking cessation by PCPs across distinct health systems.Am J Manag Care2014
24993545Using the CER Hub to ensure data quality in a multi-institution smoking cessation study.J Am Med Inform Assoc2014
24745635Automating assessment of lifestyle counseling in electronic health records.Am J Prev Med2014
21172868IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A.J Immunol2011
21176872Kaposi's sarcoma and human dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus express CCL21.J Dermatol Sci2011
20921529IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans.J Immunol2010
19295614Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis.J Invest Dermatol2009
19405866Sequelae of World War II: an outbreak of chronic cutaneous nontuberculous mycobacterial infection among Satowanese islanders.Clin Infect Dis2009
19357708Inflammatory skin disease in K5.hTGF-beta1 transgenic mice is not dependent on the IL-23/Th17 inflammatory pathway.J Invest Dermatol2009
18007580Efalizumab therapy for atopic dermatitis causes marked increases in circulating effector memory CD4+ T cells that express cutaneous lymphocyte antigen.J Invest Dermatol2008
17919774Orf-induced immunobullous disease: A distinct autoimmune blistering disorder.J Am Acad Dermatol2008
18177599Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines.Curr Rheumatol Rep2007
15728514Identification of a peptide derived from vaccinia virus A52R protein that inhibits cytokine secretion in response to TLR-dependent signaling and reduces in vivo bacterial-induced inflammation.J Immunol2005
16226431The role of Langerhans cells in the sexual transmission of HIV.J Dermatol Sci2005
14757773Activation of RAW264.7 macrophages by bacterial DNA and lipopolysaccharide increases cell surface DNA binding and internalization.J Biol Chem2004
12569622Inhibition of an activated Ras protein with genetically selected peptide aptamers.Biotechnol Bioeng2003
11528221Expression of functional melanocortin-4 receptor in the hypothalamic GT1-1 cell line.Neuroendocrinology2001
6261965The immunological role of the thymus in the pathogenesis of virus-induced lymphomas. Suppression of cytolytic T-cell function.Cell Immunol1981
6254363The induction of immunoblastic T cell sarcomas by virus-transformed prothymocytes.Am J Pathol1980
6153696Dichotomy between the induction of suppressor cells and immunologic tolerance by adult thymectomy.J Exp Med1980
389446Natural T-cell regulation of spontaneous immunoglobulin secretion.Cell Immunol1979
  • 1 - 43 of 43

Recommended Authors

Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 1
Nehme El-Hachem
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year 2011
Number of shared co-authors 0
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 1
Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Julia Carnevale
University of California san francisco
Career Start Year 2006
Number of shared co-authors 0
Emily A Stevens
Clinical Research Division, Fred Hutchinson Cancer Research Center
Career Start Year 2005
Number of shared co-authors 26
Agnes C Paquet
Universite Cote d'Azur, CNRS UMR5
Career Start Year 2004
Number of shared co-authors 0
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 1
Aleksandra A Pandyra
Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf
Career Start Year 2003
Number of shared co-authors 1
Donghui Cheng
University of California los angeles
Career Start Year 2003
Number of shared co-authors 0
Susan Geyer
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2001
Number of shared co-authors 1
Dorian LaTocha
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2000
Number of shared co-authors 23
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
David M Weinstock
Merck & Co.
Career Start Year 1998
Number of shared co-authors 4
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Eric Tse
School of Clinical Medicine, University of Hong Kong
Career Start Year 1997
Number of shared co-authors 0
Jenny Xiang
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 0
Ricky W Johnstone
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 3
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 5
Geoffrey Neale
St. Jude Children's Research Hospital
Career Start Year 1989
Number of shared co-authors 0
Nir Hacohen
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 0
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 4
Garry P Nolan
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 5
Marcela Gronda
Princess Margaret Cancer Centre
Career Start Year 1985
Number of shared co-authors 3
Thomas Decker
University of Vienna
Career Start Year 1985
Number of shared co-authors 0
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 0
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 1
Paul Brent Ferrell
Vanderbilt University
Career Start Year 1981
Number of shared co-authors 2
Robert E Lewis
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0

Collaborators

Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 16
Brian J Druker
Oregon Health & Science University
Co-authored papers 12
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 9
Andy Kaempf
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 8
Christopher A Eide
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 8
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 8
Daniel Bottomly
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 7
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 6
Alexey V Danilov
City of Hope National Medical Center
Co-authored papers 6
Motomi Mori
St Jude Children's Research Hospital.
Co-authored papers 6
Bill H Chang
Oregon Health and Science University
Co-authored papers 6
Nicola Long
Oregon Health and Science University
Co-authored papers 5
Haijiao Zhang
Oregon Health & Science University, Knight Cancer Institute
Co-authored papers 4
Ronan Swords
Oregon Health and Science University
Co-authored papers 4
Tamilla Nechiporuk
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 4
Justin M Watts
University of Miami, Sylvester Comprehensive Cancer Center
Co-authored papers 3
Christopher R Cogle
College of Medicine, University of Florida
Co-authored papers 3
Hibery Ho
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Isabel English
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Samantha L Savage
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Angela Rofelty
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Beth Wilmot
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Robert H Collins
University of Texas Southwestern Medical Center
Co-authored papers 3
Michael W Deininger
University of Utah Huntsman Cancer Institute
Co-authored papers 3
Uma Borate
The Ohio State University
Co-authored papers 3
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 3
Amanda d'Almeida
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Elie Traer
Oregon Health & Science University
Co-authored papers 3
Pierrette Lo
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Cody Coblentz
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Release 1.2